CN101700327A - Drug for treating prostatitis and preparation method - Google Patents

Drug for treating prostatitis and preparation method Download PDF

Info

Publication number
CN101700327A
CN101700327A CN200910310530A CN200910310530A CN101700327A CN 101700327 A CN101700327 A CN 101700327A CN 200910310530 A CN200910310530 A CN 200910310530A CN 200910310530 A CN200910310530 A CN 200910310530A CN 101700327 A CN101700327 A CN 101700327A
Authority
CN
China
Prior art keywords
preparation
drug
herba epimedii
effective components
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN200910310530A
Other languages
Chinese (zh)
Other versions
CN101700327B (en
Inventor
杜明珠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SWISHER TONGHUA PHARMACEUTICAL CO Ltd
Original Assignee
SWISHER TONGHUA PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SWISHER TONGHUA PHARMACEUTICAL CO Ltd filed Critical SWISHER TONGHUA PHARMACEUTICAL CO Ltd
Priority to CN2009103105305A priority Critical patent/CN101700327B/en
Publication of CN101700327A publication Critical patent/CN101700327A/en
Application granted granted Critical
Publication of CN101700327B publication Critical patent/CN101700327B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to a preparation method of a traditional Chinese medicine, in particular to a drug for treating prostatitis and a preparation method thereof. The preparation method is that 1600g of herba epimedii, 800g of raidx astragali, 600g of cattail pollen, 800g of plantain and 200g of medicinal cyathula root are used as bulk pharmaceutical chemicals and the preparation method comprises the following steps: taking a defined amount of herba epimedii, raidx astragali, cattail pollen, plantain and medicinal cyathula root to add 2000g of water to perform hot reflux and extraction for 2.5 hours, reducing pressure and concentrating the product into thick paste at the temperature of 60 DEG C, performing vacuum drying at the temperature of 60 DEG C, pulverizing into fine powder, mixing the fine powder with auxiliary materials to prepare capsules. The drug prepared by the invention has high-content effective components; the preparation efficiency and the yield are improved compared with the traditional technology; the effective components are not decomposed in the preparation process; and the content of the effective components are reserved to greatest degree, thus improving the bioavailability of the drug and having obvious advantages compared with the drug prepared by the original method.

Description

Prostatitic medicine of a kind of treatment and preparation method
Technical field
The present invention relates to a kind of Chinese medicinal preparation method, specifically is prostatitic medicine of a kind of treatment and preparation method.
Background technology
In prior art, the medicine of treatment prostatitis disease---prostate disease capsule (standard YBZ05102006) prescription is Herba Epimedii 1600g, Radix Astragali 800g, Pollen Typhae 600g, Herba Plantaginis 800g, Radix Cyathulae 200g.Preparation method is: Herba Epimedii, the Radix Astragali, Pollen Typhae, Herba Plantaginis, the Radix Cyathulae of getting ormal weight add water 2000g, decoct with water secondary, 2 hours for the first time, 1.5 hours for the second time, collecting decoction filtered, filtrate is concentrated into the extractum that relative density is 1.4 (80 ℃ of surveys), and drying is ground into fine powder, add appropriate amount of auxiliary materials, mixing is made granule, dry, encapsulated, make 1000, promptly.The product that this technology obtains is its Main Ingredients and Appearance icariin (C after testing 33H 40O 15) content is the 1.2mg/ grain.Detection method: measure according to high performance liquid chromatography (appendix VID of Chinese Pharmacopoeia version in 2005).This preparation method shortcoming is that the production time is long, and work efficiency is low, and technological temperature is too high, and its active ingredient is easily destroyed, lessens the curative effect.
Summary of the invention
The objective of the invention is provides a kind of technological effect better a kind of preparation method for the treatment of the prostatitis medicine at above-mentioned deficiency.
Technical solution of the present invention is: a kind of method for the treatment of the prostatitis medicine may further comprise the steps:
(1) crude drug is Herba Epimedii 1600g, Radix Astragali 800g, Pollen Typhae 600g, Herba Plantaginis 800g and Radix Cyathulae 200g.
(2) Herba Epimedii, the Radix Astragali, Pollen Typhae, Herba Plantaginis and the Radix Cyathulae of getting ormal weight adds water 2000g hot reflux and extracted 2.5 hours, and 60 ℃ of concentrating under reduced pressure become thick paste, and 60 ℃ of vacuum dryings are ground into fine powder, with auxiliary materials and mixing, make capsule.
Medicine Main Ingredients and Appearance icariin testing result:
Detection method is measured according to high performance liquid chromatography (appendix VID of Chinese Pharmacopoeia version in 2005).
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile-water (25: 75) is a mobile phase; The detection wavelength is 270nm; Number of theoretical plate should be not less than 3000 by the icariin peak.
It is an amount of that the preparation precision of reference substance solution takes by weighing the icariin reference substance, adds methanol and be mixed with the solution that every 1ml contains 55 μ g, promptly.
The content 0.3g under this product content uniformity item is got in the preparation of need testing solution, accurate claims surely, and the accurate 70% ethanol 50ml that adds claims decide weight, and supersound process 30 minutes is put coldly, supplies the weight that subtracts mistake with 70% ethanol, filtration, and filtrate is as need testing solution.
Accurate respectively reference substance solution and each the 10 μ l of need testing solution of drawing of algoscopy inject chromatograph of liquid, measure icariin (C 33H 40O 15) content is the 2.0mg/ grain, promptly.
Two kinds of its Main Ingredients and Appearance icariin of product (C that technology obtains 33H 40O 15) every of content differs the 0.8mg/ grain, bioavailability can improve 66%. this shows process innovation optimization after effect obvious, improved the curative effect of product greatly.
The process choice orthogonal experiments is:
The factor level table
Level A extraction time The B thickening temperature The C bake out temperature
??1 ??2.5 ??60 ??60
??2 ??3 ??80 ??80
??3 ??3.5 ??100 ??100
Orthogonal Experiment and Design table and result
Tested number Extraction time (A) Thickening temperature (B) Bake out temperature (C) Icariin content (x)
??1 ??1 ??1 ??1 ??2.06
??2 ??1 ??2 ??2 ??2.04
??3 ??1 ??3 ??3 ??1.31
??4 ??2 ??1 ??2 ??2.03
??5 ??2 ??2 ??3 ??1.96
??6 ??2 ??3 ??1 ??1.96
??7 ??3 ??1 ??3 ??1.27
??8 ??3 ??2 ??1 ??1.58
??9 ??3 ??3 ??2 ??1.21
Select optimum experimental condition to be by result of the test: 2.5 hours extraction times, thickening temperature and bake out temperature are 60 ℃.
Advantage of the present invention is: the effective ingredient content height that the present invention makes, improve work efficiency than traditional handicraft, and improve yield.Active ingredient is not decomposed in the middle of preparation process, and shows that through pharmacodynamic study its medicine effective component content is at utmost kept, thereby has improved bioavailability of medicament. have remarkable advantages than former method.
Below in conjunction with embodiment embodiments of the present invention are described in further detail.
The specific embodiment
A kind of method for the treatment of the prostatitis medicine may further comprise the steps:
1, used medicine material is Herba Epimedii 1600g, Radix Astragali 800g, Pollen Typhae 600g Herba Plantaginis 800g, Radix Cyathulae 200g.
2, Herba Epimedii, the Radix Astragali, Pollen Typhae, Herba Plantaginis, the Radix Cyathulae of getting ormal weight adds water 2000g hot reflux and extracted 2.5 hours, and 60 ℃ of concentrating under reduced pressure become thick paste, and 60 ℃ of vacuum dryings are ground into fine powder, with suitable auxiliary materials and mixing, make capsule for clinical use.

Claims (1)

1. method for the treatment of the prostatitis medicine may further comprise the steps:
(1) crude drug is Herba Epimedii 1600g, Radix Astragali 800g, Pollen Typhae 600g, Herba Plantaginis 800g and Radix Cyathulae 200g;
(2) Herba Epimedii, the Radix Astragali, Pollen Typhae, Herba Plantaginis and the Radix Cyathulae of getting ormal weight adds water 2000g hot reflux and extracted 2.5 hours, and 60 ℃ of concentrating under reduced pressure become thick paste, and 60 ℃ of vacuum dryings are ground into fine powder, with auxiliary materials and mixing, make capsule.
CN2009103105305A 2009-11-27 2009-11-27 Drug for treating prostatitis and preparation method Active CN101700327B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009103105305A CN101700327B (en) 2009-11-27 2009-11-27 Drug for treating prostatitis and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009103105305A CN101700327B (en) 2009-11-27 2009-11-27 Drug for treating prostatitis and preparation method

Publications (2)

Publication Number Publication Date
CN101700327A true CN101700327A (en) 2010-05-05
CN101700327B CN101700327B (en) 2011-02-16

Family

ID=42155271

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009103105305A Active CN101700327B (en) 2009-11-27 2009-11-27 Drug for treating prostatitis and preparation method

Country Status (1)

Country Link
CN (1) CN101700327B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940741A (en) * 2012-04-25 2013-02-27 江西普正制药有限公司 Preparation method of blood stasis-dispersing stranguria-treating capsule
CN115364165A (en) * 2020-10-28 2022-11-22 上海雷云生物科技有限公司 A topical Chinese medicinal composition for treating prostatitis, and its preparation method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940741A (en) * 2012-04-25 2013-02-27 江西普正制药有限公司 Preparation method of blood stasis-dispersing stranguria-treating capsule
CN115364165A (en) * 2020-10-28 2022-11-22 上海雷云生物科技有限公司 A topical Chinese medicinal composition for treating prostatitis, and its preparation method

Also Published As

Publication number Publication date
CN101700327B (en) 2011-02-16

Similar Documents

Publication Publication Date Title
CN113599363B (en) Preparation method of Xinmaitong capsules
CN102327401B (en) Method for preparing medicament for treating uterine bleeding
CN101700289B (en) Traditional Chinese medicine extract composition for treating gastrointestinal dysfunction or irritable bowel syndrome (IBS), and preparation method and applications thereof in preparation of medicaments
CN101057925B (en) Preparation technology for 'jieguqili' capsule
CN107854507A (en) A kind of method that flavones ingredient is extracted from folium artemisiae argyi
CN101700327B (en) Drug for treating prostatitis and preparation method
CN101647905B (en) Preparation method of influenze granule for children
AU2007357043B2 (en) Pharmaceutical composition for regulating blood sugar and fat, preparation and use thereof
CN101897873B (en) Preparation method of promoting blood circulation and removing blood stasis and soft dissolved extract
CN102688336A (en) Bezoar supernatant composite and preparation method thereof
CN1879850A (en) Capsule with hairy vein agrimony and arenobufagin, its preparation process and quality control method
CN101057895B (en) 'Fuyanshu' preparation for treating gynopathy and its quality controlling method
CN1823943A (en) Preparation technology of Chinese medicine naodesheng concentrate pill
CN102309543B (en) Compound salvia miltiorrhiza concentrated preparation and preparation and detection method thereof
CN100515476C (en) Compound capsule with pseudo-ginseng and Chinese fanpalm seed, its preparation process and quality control method
CN102590423B (en) Fingerprint spectrum determination method of ligusticum wallichii tea-blending granular preparation
CN101869644B (en) Dark-skinned chicken dispersible tablet and preparation process thereof
CN104510813A (en) Preparation method for Xinmaitong capsules
CN105878319A (en) Xiaoaiping tablet and preparation method thereof
CN102198209B (en) Tendon-relaxing and blood-activating capsules and preparation process thereof
CN105646638A (en) Preparation method of pedunculoside
KR101733048B1 (en) Improving Vascular Disorder Related Cholesterol Metabolism Food Composition Containing Solidago Virgaurea Extract and Method for Preparing the Same
CN105079134A (en) Preparation process of traditional Chinese medicine preparation used for treating cold and application of traditional Chinese medicine preparation
CN104189397B (en) Remove scorching tincture and preparation method thereof
CN104840496B (en) A kind of bupleurum root dropping pills and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant